The AMA recently shared that Alexander Ding, MD, of Kentucky and Scott Ferguson, MD, of Arkansas have been selected to the Board of Trustees by their peers. 

The ACR statement also brought to light some of the unintended consequences of the FDA’s contrast media safety warning.

The group is advocating for the NRC to treat significant extravasations in the same manner as any other reportable medical event. 

The American College of Radiology (ACR) announced this week its government relations staff has been engaging federal agencies in an effort to improve product availability and hasten resolution of the ongoing iodine contrast shortage.

Alan Matsumoto, MD, chair of the department of radiology at the University of Virginia and vice chair of the ACR Board of Chancellors, explains how the ACR and group purchasing organizations are asking the FDA to mitigate the contrast shortage with an emergency use authorization to allow non-FDA cleared iodine contrast agents to be imported.

Radiology practice leaders who begrudge requests for parental and medical leave—if any such leaders are still extant in 2022—received a bracing wakeup call in late April.

An overview for the coming January 2023 mandate to use clinical decision support for all advanced imaging orders.

Safety information for patients taking Aduhelm has been updated by the FDA to include the addition of two MRI scans during the first year of treatment.